Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-031293

Chief Executive Officer sold 15,000 shares at an average $65.25 ($978,683)

  • Chief Executive Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2020-05-19 Option exercise +4,307 $1.81 $7,796 175,833 D
Kulkarni Samarth Chief Executive Officer 2020-05-19 Sale −4,307 $65.16 $280,644 171,526 D
Kulkarni Samarth Chief Executive Officer 2020-05-20 Option exercise +10,693 $1.81 $19,354 182,219 D
Kulkarni Samarth Chief Executive Officer 2020-05-20 Sale −10,693 $65.28 $698,039 171,526 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2020-05-19 Option exercise · Stock Option (Right to Buy) −4,307 190,751 D
Kulkarni Samarth Chief Executive Officer 2020-05-20 Option exercise · Stock Option (Right to Buy) −10,693 180,058 D
Open-market sales · 15,000 sh · avg $65.25 · $978,683
Loading xslF345X03/doc4.xml…